参考文献
赵银瓶. 三氧化二砷促血管内皮化和抑制支架内再狭窄的生物学机制[D]. 重庆：重庆大学, 2018.
Benjamin E J, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the american heart association［J］. Circulation, 2019, 139（10）: e56-528.
Bennett M R, Sinha S, Owens G K. Vascular smooth muscle cells in atherosclerosis［J］. Circ Res, 2016, 118（4）: 692-702.
Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction［J］. Nature, 2011, 474（7350）: 179-183.
Fletcher D A, Mullins R D. Cell mechanics and the cytoskeleton［J］. Nature, 2010, 463（7280）: 485-492.
Gomez D, Owens G K. Smooth muscle cell phenotypic switching in atherosclerosis［J］. Cardiovasc Res, 2012, 95（2）: 156-164.
Gong F, Cheng X, Wang S, et al. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents［J］. Acta Biomater, 2010, 6（2）: 534-546.
Iaconetti C, Rosa S D, Polimeni A, et al. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo［J］. Cardiovasc Res, 2015, 107（4）: 522-533.
Izdebska M, Klimaszewska-Wiśniewska A, Lewandowski D, et al. Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line. Postep Hig Med Dosw, 2014, 68: 1492-1500.
Kimura T E, Duggirala A, Smith M C, et al. The hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP［J］. J Mol Cell Cardiol, 2016, 90: 1-10.
Libby P, Buring J E, Badimon L, et al. Atherosclerosis［J］. Nat Rev Dis Primers, 2019, 5（1）: 56.
Libby P, Ridker P M, Hansson G K. Progress and challenges in translating the biology of atherosclerosis［J］. Nature, 2011, 473（7347）: 317-325.
Ma X, Zhang H, Xue X, et al. Hypoxia-inducible factor 2alpha（HIF-2alpha）promotes colon cancer growth by potentiating Yes-associated protein 1（YAP1）activity［J］. J Biol Chem, 2017, 292（41）: 17046-17056.
Metallo C M, Heiden M G V. Understanding metabolic regulation and its influence on cell physiology［J］. Mol Cell, 2013, 49（3）: 388-398.(https://www.daowen.com)
Milutinović A, Šuput D, Zorc-Pleskovič R. Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: an updated review［J］. Bosn J Basic Med Sci, 2020, 20（1）: 21-30.
Ni F, Yu W M, Wang X, et al. Ptpn21 controls hematopoietic stem cell homeostasis and biomechanics［J］. Cell Stem Cell, 2019, 24（4）: 608-620.
Niu N, Xu S, Xu Y, et al. Targeting mechanosensitive transcription factors in atherosclerosis［J］. Trends Pharmacol Sci, 2019, 40（4）: 253-266.
Park J S, Burckhardt C J, Lazcano R, et al. Mechanical regulation of glycolysis via cytoskeleton architecture［J］. Nature, 2020, 578（7796）: 621-626.
Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond［J］. Physiol Rev, 2014, 94（4）: 1287-1312.
Rotsch C, Radmacher M. Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study［J］. Biophys J, 2000, 78（1）: 520-535.
Wang Y, Cao W, Cui J, et al. Arterial wall stress induces phenotypic switching of arterial smooth muscle cells in vascular remodeling by activating the YAP/TAZ signaling pathway［J］. Cell Physiol Biochem, 2018, 51（2）: 842-853.
Wu Q, Chen X, Wang P, et al. Delivery of arsenic trioxide by multifunction nanoparticles to improve the treatment of hepatocellular carcinoma［J］. ACS Appl Mater Interfaces, 2020, 12（7）: 8016-8029.
Yang F, Chen Q, He S, et al. MiR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation［J］. Circulation, 2018, 137（17）: 1824-1841.
Yang W, Ge J, Liu H, et al. Arsenic trioxide eluting stent reduces neointima formation in a aabbit iliac artery injury model［J］. Cardiovasc Res, 2006, 72（3）: 483-493.
Yu Q, Li W, Jin R, et al. PI3Kγ（Phosphoinositide 3-Kinase γ）regulates vascular smooth muscle cell phenotypic modulation and neointimal formation through CREB（Cyclic AMP-Response element binding brotein）/YAP（Yes-associated protein）signaling［J］. Arterioscler Thromb Vasc Biol, 2019, 39（3）: e91-e105.
Zhao Y, Du R, Zhou T, et al. Arsenic trioxide-coated stent is an endothelium-friendly drug eluting stent［J］. Adv Healthc Mater, 2018, 7（15）: e1800207.
Zhao Y, Zang G, Yin T, et al. A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway［J］. Bioact Mater, 2021, 6（2）: 375-385.